This was published in february 2006. Did not make any headlines sofar...Today NVA showed what they are interested in...deal with CTIC. Cancertreatment development...The research showed convincing results with a combination of Letrozole (NVA) & rhIGFBP3 (INSM).
Insmed was/is actively involved, as well as Leyland Jones...